1.Quality standard for Naolibao Pill
Xiaoyu HUANG ; Nuojia HUANG ; Anni MA
Chinese Traditional Patent Medicine 1992;0(03):-
AIM: To consummate the quality standard for Naolibao Pill. METHODS: Fructus Schisandrae sphenantherae,Rhizoma Acori tatarinowii,Rhizoma Chuanxiong,Vitamin E were identified by one TLC at lock in time.The Diamonsil C_(18) column was used mobile phases: methanol-isopropanol(70∶30),flow rate:1.0 mL/min,detection wavelength:284 nm for determining vitamin E;mobile phases:0.5% glacial acetic acid,flow rate:1.0 mL/min,detection wavelength:246 nm for determining Vitamin B_1. The content of Vitamin E and Vitamin B_1 were determined by HPLC. RESULTS: The average recoveries of added sample were 99.96% and 99.54%(RSD were 1.66% and 1.87%). CONCLUSION: The methods are accurate with a good reproducibility.They could be used for quality control of Naolibao Pill.
2.Effects of magnanimous therapy on the magnanimous and enterprising traits of lung cancer patients and related factors
Qihui MA ; Qingxing CHEN ; Anni YAN ; Qianyu LIU ; Lanlan WU ; Yueying WANG ; Xuewei HUANG
Chinese Journal of Behavioral Medicine and Brain Science 2020;29(1):27-32
Objective:To explore the effects of magnanimous therapy on the magnanimous and enterprising traits of lung cancer patients and the analysis of related factors.Methods:Totally 197 patients with lung cancer were divided into individual group ( n=62), team group ( n=75) and control group ( n=60). Comparison and correlation analysis were applied to the data before and after the electroencephalogram and the magnanimous questionnaire, the cancer response questionnaire, the T-type psychological scale, the cancer heart state questionnaire and the cancer patient's life function index scale. t test, analysis of variance and Pearson correlation analysis were processed by SPSS 23.0. Results:After treatment, the " enterprising" dimension and " magnanimous" dimension of individual group and the " enterprising" dimension of the team group ((3.035±0.309), (3.041±0.265), (3.173±0.371)) were higher than that before treatment((2.934±0.326), (2.908±0.315), (3.130±0.387), all P<0.05). There was negative correlation between " magnanimous" dimension of the magnanimous questionnaire and " subconscious" dimension of the T-type psychological scale in individual group( r=-0.280, P<0.05). In team group, the " enterprising" dimension of the magnanimous questionnaire was negatively correlated with " Psychological" and " Yield" dimension of the cancer heart state questionnaire( r=-0.279, -0.285, P<0.05), and positively correlated with " Facing" of the cancer response questionnaire, " Good physical condition and ability" and " Psychological well-being" dimension of the cancer patient's life function index scale( r=0.367, 0.402, 0.379, P<0.05). There was a negative correlation between the " enterprising" dimension of the magnanimous questionnaire and the beta wave value in individual group. Conclusion:The magnanimous therapy can improve enterprising and magnanimous level of patients with lung cancer, and the effects are related with the above-mentioned psychosomatic factors.